Docoh
Loading...

ICCC Immucell

ImmuCell Corp. engages in the development, acquisition, manufacture and sale of products that improve the health and productivity of cows for the dairy and beef industries. Its products include first defense for scours, California mastitis test kit and purified nisin intramammary treatment for mastitis. The company was founded in 1982 and is headquartered in Portland, ME.

Company profile

ICCC stock data

(
)

Investment data

Data from SEC filings
Securities sold
Number of investors

Calendar

30 Mar 21
13 Apr 21
31 Dec 21
Quarter (USD)
Dec 20 Sep 20 Jun 20 Mar 20
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS
Annual (USD)
Dec 20 Dec 19 Dec 18 Dec 17
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Financial data from Immucell earnings reports.

Cash burn rate (estimated) Burn method: Change in cash Burn method: Operating income/loss Burn method: FCF (opex + capex)
Last Q Avg 4Q Last Q Avg 4Q Last Q Avg 4Q
Cash on hand (at last report) 6.95M 6.95M 6.95M 6.95M 6.95M 6.95M
Cash burn (monthly) (positive/no burn) (positive/no burn) 211.45K 127.18K (positive/no burn) (positive/no burn)
Cash used (since last report) n/a n/a 730.89K 439.6K n/a n/a
Cash remaining n/a n/a 6.22M 6.51M n/a n/a
Runway (months of cash) n/a n/a 29.4 51.2 n/a n/a

Beta Read what these cash burn values mean

Date Owner Security Transaction Code Indirect 10b5-1 $Price #Shares $Value #Remaining
8 Dec 20 Bobbi Jo Brockmann Common Stock, par value $0.10 per share Grant Aquire A No No 3.15 4,742 14.94K 8,521
8 Dec 20 Bobbi Jo Brockmann Incentive Stock Options Common Stock Sale back to company Dispose D No No 3.15 5,258 16.56K -
12 Mar 20 David Cunningham Common Stock, par value $0.10 per share Buy Aquire P No No 4 2,000 8K 15,000
11 Mar 20 David Scott Tomsche Common Stock, par value $0.10 per share Buy Aquire P No No 4.28 4,600 19.69K 85,519
27 Feb 20 David Scott Tomsche Common Stock, par value $0.10 per share Buy Aquire P No No 4.98 5,130 25.55K 80,919
11 Dec 19 Elizabeth Luttrell Williams Incentive Stock Options Common Stock Grant Aquire A No No 5.175 10,000 51.75K 10,000

Data for the last complete 13F reporting period. To see the most recent changes to ownership, click the ownership history button above.

10.0% owned by funds/institutions
13F holders
Current Prev Q Change
Total holders 25 27 -7.4%
Opened positions 2 4 -50.0%
Closed positions 4 1 +300.0%
Increased positions 5 2 +150.0%
Reduced positions 4 6 -33.3%
13F shares
Current Prev Q Change
Total value 4.31M 3.88M +11.2%
Total shares 724K 714.38K +1.3%
Total puts 0 0
Total calls 0 0
Total put/call ratio
Largest owners
Shares Value Change
Renaissance Technologies 168.15K $1M +7.7%
Vanguard 93.38K $556K 0.0%
Overbrook Management 88.03K $524K 0.0%
MS Morgan Stanley 57.57K $343K 0.0%
Perritt Capital Management 55K $327K -8.3%
Shufro Rose & Co 50.67K $301K 0.0%
Strategic Financial Services, Inc, 30.03K $179K 0.0%
HM Payson & Co 20.5K $122K -30.5%
Geode Capital Management 20.43K $121K 0.0%
BLK Blackrock 17.49K $105K +4.5%
Largest transactions
Shares Bought/sold Change
Essex Financial Services 0 -20K EXIT
Prosperity Planning 15K +15K NEW
Renaissance Technologies 168.15K +12.03K +7.7%
Envestnet Asset Management 11.2K +11.2K NEW
HM Payson & Co 20.5K -9K -30.5%
Perritt Capital Management 55K -5K -8.3%
HighTower Advisors 16.87K +3.5K +26.2%
NTRS Northern Trust 12.87K +1.27K +11.0%
UBS UBS Group AG - Registered Shares 3.37K +1.05K +45.4%
C Citigroup 0 -930 EXIT

Financial report summary

?
Competition
PfizerZoetis
Content analysis
?
Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability
H.S. sophomore Good
New words: abnormal, accrual, ago, aspect, automatically, Basse, behavior, belief, borrowing, bridge, broader, buildup, California, cancel, cancelled, candidate, Consumer, corridor, COVID, curtailing, deeper, deliberate, depleted, devaluation, DHIA, diagnose, dumped, dumping, dysgalactiae, ease, eased, easily, educating, embrace, expended, expiry, explore, extra, fabrication, Facilitation, FD, flexibility, fluctuation, forgiven, Gloria, GSB, guideline, hard, home, implicit, indirect, inducing, Interbank, knock, landlord, learning, leasehold, length, lessee, load, London, lunch, methodology, moderately, motivate, motivated, neutralization, notably, online, Overview, parking, particle, Paycheck, payroll, penalty, PPP, predecessor, prepay, proceeding, prudent, recovered, recurring, Reform, relieved, remote, road, ROU, sensitivity, situation, stay, subordinated, superseded, throughput, understood, unmet, unstable, urgent, virtual, visual, VLP, waive
Removed: accepting, Accountingto, adjusted, Amherst, andCMT, annually, antibacterial, apply, assigned, award, bear, bioterrorism, bivalentFirst, bull, byFirst, China, clarity, combating, comply, consolidated, contemplate, converted, corroborated, designated, developedCalifornia, disposed, diversity, dominated, Europe, expandingFirst, FASBAccounting, floating, flow, formally, formulating, hedged, hedging, housing, IMMUNITYtrademark, inPart, integration, introducedFirst, machinery, Mankato, MN, modification, necessarily, norm, notional, offersImmediate, ofFirst, offsetting, ourfirst, ourIMMEDIATE, overvalued, peptide, problematic, provideImmediate, renewed, returned, reviewPart, Ridley, risen, save, sellFirst, slightly, terrorism, thatFirst, theE, thefirst, threat, unaudited, underpart, understand, unusually, USA, weakened, withFirst, withPart